BioSpace News Archive

Viemed Healthcare, Inc., a national leader in respiratory care and technology-enabled home medical equipment services, reported its financial results for the three months and year ended December 31, 2022.

Extendicare Inc. reported results for the three and twelve months ended December 31, 2022.

Revolution Medicines, Inc., a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, announced the pricing of its underwritten public offering of 13,636,364 shares of common stock at a public offering price of $22.00 per share, before underwriting discounts and commissions.

Mirion Technologies, Inc. announced the pricing of an underwritten public offering of 9,786,153 shares of Mirion’s Class A common stock by certain selling stockholders at a price to the public of $8.75 per share.